<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03710993</url>
  </required_header>
  <id_info>
    <org_study_id>PR 2018-290</org_study_id>
    <nct_id>NCT03710993</nct_id>
  </id_info>
  <brief_title>Accuracy Assessment of Beddr Oximeter</brief_title>
  <official_title>Beddr Sleep SpO2 Equivalency Calibration Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hancock Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hancock Medical, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Accuracy performance of Beddr oximeter&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate the accuracy of the Beddr sleepTuner oximeter compared to a transfer&#xD;
      standard and multiple reference devices.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 30, 2018</start_date>
  <completion_date type="Actual">August 3, 2018</completion_date>
  <primary_completion_date type="Actual">August 3, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SpO2 accuracy</measure>
    <time_frame>60 minutes</time_frame>
    <description>Collect and analyze data to assess SpO2 calibration and accuracy</description>
  </primary_outcome>
  <enrollment type="Actual">15</enrollment>
  <condition>Oximetry</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>oximeter</intervention_name>
    <description>Participants breathe a controlled gas mixture to induce several reduced oxygen states while oximeter measurements are taken for comparison to corresponding transfer standard and reference devices to assess oximeter calibration and accuracy.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy adult volunteers, ranging in pigmentation from light to dark.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject must have the ability to understand and provide written informed consent&#xD;
&#xD;
          -  Adult subjects 18 up to 50 years of age&#xD;
&#xD;
          -  Subject must be willing and able to comply with study procedures and duration&#xD;
&#xD;
          -  Subject is a non-smoker or who has not smoked within 2 days prior to the study.&#xD;
&#xD;
          -  Male or female of any race&#xD;
&#xD;
          -  Subject demographics include a range of skin pigmentations, including at least 1&#xD;
             darkly pigmented subjects or 15% of the subject pool, whichever is larger.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject is considered as being morbidly obese (defined as BMI &gt;39.5)&#xD;
&#xD;
          -  Compromised circulation, injury, or physical malformation of fingers, toes, hands,&#xD;
             ears or forehead/skull or other sensor sites which would limit the ability to test&#xD;
             sites needed for the study. (Note: Certain malformations may still allow subjects to&#xD;
             participate if the condition is noted and would not affect the particular sites&#xD;
             utilized.)&#xD;
&#xD;
          -  Females who are pregnant, who are trying to get pregnant or who have a urine test&#xD;
             positive for pregnancy on the day of the study&#xD;
&#xD;
          -  Subjects with known respiratory conditions such as:&#xD;
&#xD;
               -  uncontrolled / severe asthma,&#xD;
&#xD;
               -  flu,&#xD;
&#xD;
               -  pneumonia / bronchitis,&#xD;
&#xD;
               -  shortness of breath / respiratory distress,&#xD;
&#xD;
               -  unresolved respiratory or lung surgery with continued indications of health&#xD;
                  issues,&#xD;
&#xD;
               -  emphysema, COPD, lung disease&#xD;
&#xD;
          -  Subjects with known heart or cardiovascular conditions such as:&#xD;
&#xD;
               -  Hypertension: systolic &gt;140mmHg, Diastolic &gt;90mmHg on 3 consecutive readings.&#xD;
&#xD;
               -  have had cardiovascular surgery&#xD;
&#xD;
               -  Chest pain (angina)&#xD;
&#xD;
               -  heart rhythms other than a normal sinus rhythm or with respiratory sinus&#xD;
                  arrhythmia&#xD;
&#xD;
               -  previous heart attack&#xD;
&#xD;
               -  blocked artery&#xD;
&#xD;
               -  unexplained shortness of breath&#xD;
&#xD;
               -  congestive heart failure (CHF)&#xD;
&#xD;
               -  history of stroke&#xD;
&#xD;
               -  transient ischemic attack&#xD;
&#xD;
               -  carotid artery disease&#xD;
&#xD;
               -  myocardial ischemia&#xD;
&#xD;
               -  myocardial infarction&#xD;
&#xD;
               -  cardiomyopathy&#xD;
&#xD;
          -  Self-reported health conditions as identified in the Health Assessment Form&#xD;
&#xD;
               -  diabetes,&#xD;
&#xD;
               -  uncontrolled thyroid disease,&#xD;
&#xD;
               -  kidney disease / chronic renal impairment,&#xD;
&#xD;
               -  history of seizures (except childhood febrile seizures),&#xD;
&#xD;
               -  epilepsy,&#xD;
&#xD;
               -  history of unexplained syncope,&#xD;
&#xD;
               -  recent history of frequent migraine headaches,&#xD;
&#xD;
               -  recent head injury within the last 2 months,&#xD;
&#xD;
               -  cancer / chemotherapy&#xD;
&#xD;
          -  Subjects with known clotting disorders&#xD;
&#xD;
               -  history of bleeding disorders or personal history of prolonged bleeding from&#xD;
                  injury&#xD;
&#xD;
               -  history of blood clots&#xD;
&#xD;
               -  hemophilia&#xD;
&#xD;
               -  current use of blood thinner: prescription or daily use of aspirin&#xD;
&#xD;
          -  Subjects with Severe contact allergies to standard adhesives, latex or other materials&#xD;
             found in pulse oximetry sensors, ECG electrodes, respiration monitor electrodes or&#xD;
             other medical sensors&#xD;
&#xD;
          -  Unwillingness or inability to remove colored nail polish or non-clear artificial nails&#xD;
             from test digits.&#xD;
&#xD;
          -  Other known health condition, should be considered upon disclosure in health&#xD;
             assessment form&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arthur Cabrera, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinimark, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinimark</name>
      <address>
        <city>Louisville</city>
        <state>Colorado</state>
        <zip>80027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 16, 2018</study_first_submitted>
  <study_first_submitted_qc>October 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2018</study_first_posted>
  <last_update_submitted>October 16, 2018</last_update_submitted>
  <last_update_submitted_qc>October 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

